{"id":"W2120642008","doi":"10.1093/annonc/mdl056","title":"Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research; Hôpital Notre-Dame; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Temozolomide; Oncology; Clinical trial; Breast cancer; Internal medicine; Cancer; Gynecology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003882905,0.0001530303,0.001452743,0.0001068203,0.00004107888,0.000001445373,0.0001370923,0.0001014547,0.0002745193],"category_scores_gemma":[0.001075222,0.00009691819,0.0003462672,0.0002929665,0.0003005448,0.0000492092,0.00005368555,0.0001757859,2.486878e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002144639,"about_ca_system_score_gemma":0.005828063,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3980462,"about_ca_topic_score_gemma":0.5813831,"domain_scores_codex":[0.996385,0.0008193912,0.001842312,0.0002284408,0.0004802255,0.0002446123],"domain_scores_gemma":[0.9972329,0.0009670046,0.00114295,0.0001909115,0.0003821131,0.00008416323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2323135,0.05450231,0.02770627,0.0006660343,0.006194255,0.0003172365,0.0003276781,0.002039983,0.006445235,0.01028891,0.2803739,0.3788247],"study_design_scores_gemma":[0.520524,0.02433231,0.1533262,0.0007336443,0.002539593,0.0001395313,0.0001814042,0.0004163378,0.01006579,0.003078474,0.2841912,0.0004715271],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747452,0.0008926691,0.000009431318,0.0197946,0.001068264,0.001106453,0.001508877,0.00000339909,0.0008710776],"genre_scores_gemma":[0.9969948,0.0003225142,0.0003039754,0.001562402,0.0003991576,0.0001436017,0.00003800603,0.00001045145,0.0002250979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3783531,"threshold_uncertainty_score":0.999808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2658599610808156,"score_gpt":0.5287769800145659,"score_spread":0.2629170189337503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}